L2F

N-(1-naphthylsulfonyl)-(L)-isoleucyl-(L)-tryptophanol

Created:	2022-06-14
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where L2F is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	66
Chiral Atom Count	3
Bond Count	69
Aromatic Bond Count	21

2D diagram of L2F

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-(1-naphthylsulfonyl)-(L)-isoleucyl-(L)-tryptophanol
Synonyms	(2~{S},3~{S})-~{N}-[(2~{S})-1-(1~{H}-indol-3-yl)-3-oxidanyl-propan-2-yl]-3-methyl-2-(naphthalen-1-ylsulfonylamino)pentanamide
Systematic Name (OpenEye OEToolkits)	(2~{S},3~{S})-~{N}-[(2~{S})-1-(1~{H}-indol-3-yl)-3-oxidanyl-propan-2-yl]-3-methyl-2-(naphthalen-1-ylsulfonylamino)pentanamide
Formula	C₂₇ H₃₁ N₃ O₄ S
Molecular Weight	493.618
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CC[CH](C)[CH](N[S](=O)(=O)c1cccc2ccccc12)C(=O)N[CH](CO)Cc3c[nH]c4ccccc34
SMILES	OpenEye OEToolkits	2.0.7	CCC(C)C(C(=O)NC(Cc1c[nH]c2c1cccc2)CO)NS(=O)(=O)c3cccc4c3cccc4
Canonical SMILES	CACTVS	3.385	CC[C@H](C)[C@H](N[S](=O)(=O)c1cccc2ccccc12)C(=O)N[C@H](CO)Cc3c[nH]c4ccccc34
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC[C@H](C)[C@@H](C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)CO)NS(=O)(=O)c3cccc4c3cccc4
InChI	InChI	1.06	InChI=1S/C27H31N3O4S/c1-3-18(2)26(30-35(33,34)25-14-8-10-19-9-4-5-12-23(19)25)27(32)29-21(17-31)15-20-16-28-24-13-7-6-11-22(20)24/h4-14,16,18,21,26,28,30-31H,3,15,17H2,1-2H3,(H,29,32)/t18-,21-,26-/m0/s1
InChIKey	InChI	1.06	WGQRDHFZEVLIFE-JCWFFFCVSA-N

Related Resource References

Resource Name	Reference
PubChem	11799355

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.